Prostate Cancer Reports


Volume 2 Number 11
November 2014

Home > Prostate Cancer Reports > Volume 2 - Year 2014 > Number 11, November 2014

CONTENTS



Detection, diagnosis and evaluation
Epidemiology and risk factors
Etiology and pathogenesis
Integrative medicine
Overall management
Prevention and screening
Prognosis and outcome
Prostate-specific antigen
Quality of life
Staging
Treatment


DETECTION, DIAGNOSIS AND EVALUATION



Lista F, Castillo E, Gimbernat H, Rodríguez-Barbero JM, Panizo J, Angulo JC.
Multiparametric magnetic resonance imaging predicts the presence of prostate cancer in patients with negative prostate biopsy.
Actas Urol Esp. 2014 Sep 26. pii: S0210-4806(14)00306-4. doi: 10.1016/j.acuro.2014.07.001. [Epub ahead of print]
Abstract | Related citations


Zhao R, Huang Y, Cheng G, Liu J, Shao P, Qin C, Hua L, Yin C.
Developing a follow-up strategy for patients with PSA ranging from 4 to 10 ng/ml via a new model to reduce unnecessary prostate biopsies.
PLoS One. 2014 Sep 30;9(9):e106933. doi: 10.1371/journal.pone.0106933. eCollection 2014.
Abstract | Full text | Related citations

EPIDEMIOLOGY AND RISK FACTORS



Klap J, Schmid M, Loughlin KR.
The Relationship between Total Testosterone Levels and Prostate Cancer: A Review of the Continuing Controversy.
J Urol. 2014 Sep 28. pii: S0022-5347(14)04490-5. doi: 10.1016/j.juro.2014.07.123. [Epub ahead of print]
Abstract | Related citations


Steinberger E, Kollmeier M, McBride S, Novak C, Pei X, Zelefsky MJ.
Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity.
BJU Int. 2014 Oct 23. doi: 10.1111/bju.12969. [Epub ahead of print]
Abstract | Related citations

ETIOLOGY AND PATHOGENESIS



Berman-Booty LD, Knudsen K.
Models of neuroendocrine prostate cancer.
Endocr Relat Cancer. 2014 Oct 27. pii: ERC-14-0393. [Epub ahead of print]
Abstract | Full text | Related citations


Shtivelman E, Beer TM, Evans CP.
Molecular pathways and targets in prostate cancer.
Oncotarget. 2014 Sep 15;5(17):7217-59.
Abstract | Full text | Related citations


Zhou Y, Bolton EC, Jones JO.
Androgens and androgen receptor signaling in prostate tumorigenesis.
J Mol Endocrinol. 2015 Feb;54(1):R15-R29. Epub 2014 Oct 28.
Abstract | Full text | Related citations

INTEGRATIVE MEDICINE



Erren TC, Slanger TE, Groß JV, Reiter RJ.
Melatonin, Sleep, and Prostate Cancer in Elderly Men: Study, Hypothesis Development, and Icelandic Options.Melatonin, Sleep, and Prostate Cancer in Elderly Men: Study, Hypothesis Development, and Icelandic Options.
Eur Urol. 2014 Oct 1. pii: S0302-2838(14)00970-1. doi: 10.1016/j.eururo.2014.09.033. [Epub ahead of print]
Abstract | Full text | Related citations


Freedland SJ.
The effect of diet and supplements on prostate cancer.
Clin Adv Hematol Oncol. 2014 Aug;12(8):538-40.
Abstract | Full text | Related citations

OVERALL MANAGEMENT



Intraductal carcinoma of the prostate

Bonkhoff H, Wheeler TM, van der Kwast TH, Magi-Galluzzi C, Montironi R, Cohen RJ.
Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer?
Prostate. 2013 Mar;73(4):442-8. doi: 10.1002/pros.22579. Epub 2012 Sep 4.
Abstract | Related citations


Guo CC, Epstein JI.
Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance.
Mod Pathol. 2006 Dec;19(12):1528-35. Epub 2006 Sep 15.
Abstract | Full text | Related citations


Roberts JA, Zhou M, Park YW, Ro JY.
Intraductal carcinoma of prostate: a comprehensive and concise review.
Korean J Pathol. 2013 Aug;47(4):307-15. doi: 10.4132/KoreanJPathol.2013.47.4.307. Epub 2013 Aug 26. Erratum in: Korean J Pathol. 2013 Oct;47(5):502. Park, Yong Wok [corrected to Park, Yong Wook].
Abstract | Full text | Erratum | Related citations


Robinson B, Magi-Galluzzi C, Zhou M.
Intraductal carcinoma of the prostate.
Arch Pathol Lab Med. 2012 Apr;136(4):418-25. doi: 10.5858/arpa.2011-0519-RA.
Abstract | Full text | Related citations


Zhou M.
Intraductal carcinoma of the prostate: the whole story.
Pathology. 2013 Oct;45(6):533-9. doi: 10.1097/PAT.0b013e3283653322
Abstract | Related citations

PREVENTION AND SCREENING



Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, Culig Z, Eeles RA, Ford LG, Hamdy FC, Holmberg L, Ilic D, Key TJ, La Vecchia C, Lilja H, Marberger M, Meyskens FL, Minasian LM, Parker C, Parnes HL, Perner S, Rittenhouse H, Schalken J, Schmid HP, Schmitz-Dräger BJ, Schröder FH, Stenzl A, Tombal B, Wilt TJ, Wolk A.
Prevention and early detection of prostate cancer.
Lancet Oncol. 2014 Oct;15(11):e484-92. doi: 10.1016/S1470-2045(14)70211-6.
Abstract | Related citations

PROGNOSIS AND OUTCOME



Lightfoot AJ, Su YK, Sehgal SS, Lee Z, Greaves GH, Yu SJ, Llukani E, Su YC, Lee D.
Positive Surgical Margin Trends In Patients With Pathologic T3 Prostate Cancer Treated With Robot Assisted Radical Prostatectomy.
J Endourol. 2014 Oct 30. [Epub ahead of print]
Abstract | Related citations


Miyoshi Y, Uemura H, Umemoto S, Sakamaki K, Morita S, Suzuki K, Shibata Y, Masumori N, Ichikawa T, Mizokami A, Sugimura Y, Nonomura N, Sakai H, Honma S, Harada M, Kubota Y.
High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.
BMC Cancer. 2014 Sep 26;14:717. doi: 10.1186/1471-2407-14-717.
Abstract | Full text | Related citations


Intraductal carcinoma of the prostate

Zhao T, Liao B, Yao J, Liu J, Huang R, Shen P, Peng Z, Gui H, Chen X, Zhang P, Zhu Y, Li X, Wei Q, Zhou Q, Zeng H, Chen N.
Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer?
Prostate. 2014 Oct 13. doi: 10.1002/pros.22906. [Epub ahead of print]
Abstract | Related citations

PROSTATE-SPECIFIC ANTIGEN


Lundon D, Loeb S.
Prostate-specific Antigen Velocity Risk Count to Discern Significant From Indolent Prostate Cancer.
Rev Urol. 2014;16(3):154-6
Abstract | Full text | Related citations

QUALITY OF LIFE



Gur S, Sikka SC, Kadowitz PJ, Silberstein J, Hellstrom WJ.
2014 Update Of Erectile Dysfunction Management Following Radical Prostatectomy: From Basic Research To Clinical Management.
Curr Pharm Des. 2014 Oct 29. [Epub ahead of print]
Abstract | Related citations

STAGING



Cedeño Díaz OM, Fernández Aceñero MJ, Alvarez Fernández E.
Prognostic influence of the third Gleason grade in prostatectomy specimens.
Urol Oncol. 2012 Jul-Aug;30(4):386-90. doi: 10.1016/j.urolonc.2010.05.007. Epub 2011 Feb 2.
Abstract | Related citations


D'Elia C, Cerruto MA, Cioffi A, Novella G, Cavalleri S, Artibani W.
Upgrading and upstaging in prostate cancer: From prostate biopsy to radical prostatectomy.
Mol Clin Oncol. 2014 Nov;2(6):1145-1149. Epub 2014 Aug 5.
Abstract | Full text | Related citations


Grasso AA, Cozzi G, Palumbo C, Albo G, Rocco B.
Concordance between biopsy and radical prostatectomy specimen Gleason score in internal and external pathology facilities.
Anticancer Res. 2014 Oct;34(10):5585-8.
Abstract | Related citations


Klaassen Z, Huang J, Tatem AJ, Terris MK.
Words of wisdom. Re: Prognostic influence of the third Gleason grade in prostatectomy specimens.
Eur Urol. 2014 Feb;65(2):498-9. doi: 10.1016/j.eururo.2013.10.051.
Abstract | Full text | Related citations

TREATMENT



Gnanapragasam VJ, Mason MD, Shaw GL, Neal DE.
The role of surgery in high-risk localised prostate cancer.
BJU Int. 2012 Mar;109(5):648-58. doi: 10.1111/j.1464-410X.2011.10596.x. Epub 2011 Sep 27.
Abstract | Full text | Related citations


Kang HW, Lee JY, Kwon JK, Jeh SU, Jung HD, Choi YD.
Current status of radical prostatectomy for high-risk prostate cancer.
Korean J Urol. 2014 Oct;55(10):629-35. doi: 10.4111/kju.2014.55.10.629. Epub 2014 Oct 10.
Abstract | Full text | Related citations


Kim YJ, Cho KH, Pyo HR, Lee KH, Moon SH, Kim TH, Shin KH, Kim JY, Kim YK, Lee SB.
Radical prostatectomy versus external beam radiotherapy for localized prostate cancer : Comparison of treatment outcomes.
Strahlenther Onkol. 2014 Oct 23. [Epub ahead of print]
Abstract | Related citations


Kwon O, Kim TJ, Lee IJ, Byun SS, Lee SE, Hong SK.
Can contemporary patients with biopsy Gleason score 3+4 be eligible for active surveillance?
PLoS One. 2014 Sep 30;9(9):e109031. doi: 10.1371/journal.pone.0109031. eCollection 2014.
Abstract | Full text | Related citations


Taplin ME, Montgomery B, Logothetis CJ, Bubley GJ, Richie JP, Dalkin BL, Sanda MG, Davis JW, Loda M, True LD, Troncoso P, Ye H, Lis RT, Marck BT, Matsumoto AM, Balk SP, Mostaghel EA, Penning TM, Nelson PS, Xie W, Jiang Z, Haqq CM, Tamae D, Tran N, Peng W, Kheoh T, Molina A, Kantoff PW.
Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study.
J Clin Oncol. 2014 Nov 20;32(33):3705-15. doi: 10.1200/JCO.2013.53.4578. Epub 2014 Oct 13.
Abstract | Related citations


Thurairaja R, Koupparis A.
The role of surgery in high-risk localised prostate cancer.
BJU Int. 2012 Jul;110(1):E1-2. doi: 10.1111/j.1464-410X.2012.11303_2.x.
Abstract | Full text | Related citations


Van Poppel H.
Words of wisdom. Re: The role of surgery in high-risk localized prostate cancer.
Eur Urol. 2014 Aug;66(2):387-9. doi: 10.1016/j.eururo.2014.05.020
Abstract | Full text | Related citations